Picture of IDEXX Laboratories logo

IDXX — IDEXX Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: IDEXX Q4 EPS USD 2.62 Vs. IBES Estimate USD 2.4

Feb 03 (Reuters) - IDEXX Q4 EBIT margin 27.4%.
* Q4 revenue USD 954 million vs. IBES estimate USD 935 million
* Q4 gross margin 59.8%
* outlook FY EPS USD 11.74-12.24
* outlook FY revenue USD 4,055-4,170 million
* outlook FY revenue growth 4-7%

Recent news on IDEXX Laboratories

See all news